OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
Cristiano Schaffer Aguzzoli, Pâmela C.L. Ferreira, Guilherme Povala, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2345175-e2345175
Open Access | Times Cited: 25
Cristiano Schaffer Aguzzoli, Pâmela C.L. Ferreira, Guilherme Povala, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2345175-e2345175
Open Access | Times Cited: 25
Showing 25 citing articles:
Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer’s Disease
Efthalia Angelopoulou, Christos Koros, Alexandros Hatzimanolis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2645-2645
Open Access | Times Cited: 9
Efthalia Angelopoulou, Christos Koros, Alexandros Hatzimanolis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2645-2645
Open Access | Times Cited: 9
Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease
Myuri Ruthirakuhan, Dylan X. Guan, Moyra E. Mortby, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Myuri Ruthirakuhan, Dylan X. Guan, Moyra E. Mortby, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis
Erwin Lemche, Richard Killick, Jackie Mitchell, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106485-106485
Open Access | Times Cited: 7
Erwin Lemche, Richard Killick, Jackie Mitchell, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106485-106485
Open Access | Times Cited: 7
Microglial Senescence and Activation in Healthy Aging and Alzheimer’s Disease: Systematic Review and Neuropathological Scoring
Antonio Malvaso, Alberto Gatti, G Negro, et al.
Cells (2023) Vol. 12, Iss. 24, pp. 2824-2824
Open Access | Times Cited: 12
Antonio Malvaso, Alberto Gatti, G Negro, et al.
Cells (2023) Vol. 12, Iss. 24, pp. 2824-2824
Open Access | Times Cited: 12
GWAS linksAPOEto neuropsychiatric symptoms in mild cognitive impairment and dementia
Selina Vattathil, Freida Blostein, Tyne W. Miller‐Fleming, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Selina Vattathil, Freida Blostein, Tyne W. Miller‐Fleming, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Modulating inflammatory prostaglandin E2 signaling to mitigate neurobehavioral comorbidities associated with seizure disorders
Chenyao Jiang, Ying Yu, Jiawang Liu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Chenyao Jiang, Ying Yu, Jiawang Liu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Mapping the Neuropsychiatric Symptoms in Alzheimer’s Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review
Athanasios Chatzikostopoulos, Despina Μoraitou, Vasileios Papaliagkas, et al.
Diagnostics (2025) Vol. 15, Iss. 9, pp. 1082-1082
Open Access
Athanasios Chatzikostopoulos, Despina Μoraitou, Vasileios Papaliagkas, et al.
Diagnostics (2025) Vol. 15, Iss. 9, pp. 1082-1082
Open Access
Neuroinflammation mediates the progression of neonate hypoxia-ischemia brain damage to Alzheimer’s disease: a bioinformatics and experimental study
Shengjie Zhang, Ruqiu Zhang, Zhaoqin Chen, et al.
Frontiers in Aging Neuroscience (2025) Vol. 16
Open Access
Shengjie Zhang, Ruqiu Zhang, Zhaoqin Chen, et al.
Frontiers in Aging Neuroscience (2025) Vol. 16
Open Access
Investigating neuropathological correlates of hyperactive and psychotic symptoms in dementia: a systematic review
G Negro, Michele Rossi, Camillo Imbimbo, et al.
Frontiers in Dementia (2025) Vol. 4
Open Access
G Negro, Michele Rossi, Camillo Imbimbo, et al.
Frontiers in Dementia (2025) Vol. 4
Open Access
Neuroinflammatory fluid biomarkers in patients with Alzheimer’s disease: a systematic literature review
Michael T. Heneka, Serge Gauthier, Sagar Anil Chandekar, et al.
Molecular Psychiatry (2025)
Open Access
Michael T. Heneka, Serge Gauthier, Sagar Anil Chandekar, et al.
Molecular Psychiatry (2025)
Open Access
Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer’s and Parkinson’s disease
Faye T.C. Lau, Rebecca Binacchi, S. Brugnara, et al.
Neuroscience (2025)
Open Access
Faye T.C. Lau, Rebecca Binacchi, S. Brugnara, et al.
Neuroscience (2025)
Open Access
Monoamine signaling and neuroinflammation: mechanistic connections and implications for neuropsychiatric disorders
Shalini Saggu, Andrew Pless, Emily Dew, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Shalini Saggu, Andrew Pless, Emily Dew, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Comparison of 18F-DPA714 PET/MRI and 18F-FDG PET/CT in patients with autoimmune encephalitis: a cross-sectional study
Huanyu Meng, Xiaoyu Chen, Lu He, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Huanyu Meng, Xiaoyu Chen, Lu He, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
OTUD1 positively regulates microglia neuroinflammation and promotes the pathogenesis of Alzheimer’s disease by deubiquitinating C/EBPβ
Lingyu She, Luyao Li, Hao Tang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Lingyu She, Luyao Li, Hao Tang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Beyond memory impairment: the complex phenotypic landscape of Alzheimer’s disease
Stathis Argyriou, John F. Fullard, Josh M. Krivinko, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 713-722
Closed Access | Times Cited: 2
Stathis Argyriou, John F. Fullard, Josh M. Krivinko, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 713-722
Closed Access | Times Cited: 2
Efficacy of a synbiotic in the management of adults with Attention-Deficit and Hyperactivity Disorder and/or Borderline Personality Disorder and high levels of irritability: Results from a multicenter, randomized, placebo-controlled, “basket” trial
Gara Arteaga-Henríquez, Carolina Ramos-Sayalero, Pol Ibañez-Jiménez, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 360-371
Open Access | Times Cited: 2
Gara Arteaga-Henríquez, Carolina Ramos-Sayalero, Pol Ibañez-Jiménez, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 360-371
Open Access | Times Cited: 2
Apocynin Prevents Cigarette Smoke-Induced Anxiety-Like Behavior and Preserves Microglial Profiles in Male Mice
Rana Alateeq, Alina Akhtar, Simone N. De Luca, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 855-855
Open Access | Times Cited: 2
Rana Alateeq, Alina Akhtar, Simone N. De Luca, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 855-855
Open Access | Times Cited: 2
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression
Miriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Miriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Associations Between Neuropsychiatric Symptoms and Inflammation in Neurodegenerative Dementia: A Systematic Review
Peter Swann, Anastasia Mirza-Davies, John T. O’Brien
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6113-6141
Open Access | Times Cited: 2
Peter Swann, Anastasia Mirza-Davies, John T. O’Brien
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6113-6141
Open Access | Times Cited: 2
Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging
Arthur C. Macedo, Joseph Therriault, Cécile Tissot, et al.
Neurobiology of Aging (2024) Vol. 144, pp. 127-137
Open Access | Times Cited: 2
Arthur C. Macedo, Joseph Therriault, Cécile Tissot, et al.
Neurobiology of Aging (2024) Vol. 144, pp. 127-137
Open Access | Times Cited: 2
Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer’s Disease
Camillo Imbimbo, Matteo Cotta Ramusino, Silvia Leone, et al.
CNS Drugs (2024)
Open Access | Times Cited: 2
Camillo Imbimbo, Matteo Cotta Ramusino, Silvia Leone, et al.
CNS Drugs (2024)
Open Access | Times Cited: 2
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression
Miriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Miriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
18F-DPA714 PET/MRI as a potential imaging tool for detecting possible antibody-negative autoimmune encephalitis: a prospective study
Huanyu Meng, Lu He, Hangxing Chunyu, et al.
Journal of Neurology (2024)
Closed Access | Times Cited: 1
Huanyu Meng, Lu He, Hangxing Chunyu, et al.
Journal of Neurology (2024)
Closed Access | Times Cited: 1
Drug Delivery Targeting Neuroinflammation to Treat Brain Diseases
Juntao Wang, Ruiqin Jia, Wubo Wan, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 11, pp. 1687-1698
Closed Access | Times Cited: 1
Juntao Wang, Ruiqin Jia, Wubo Wan, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 11, pp. 1687-1698
Closed Access | Times Cited: 1
